GAO: FDA fails to follow up on unproven drugs
By MATTHEW PERRONE, AP Business Writer Matthew Perrone, Ap Business Writer – 1 hr 58 mins ago
WASHINGTON – The Food and Drug Administration has allowed drugs for cancer and other diseases to stay on the market even when follow-up studies showed they didn’t extend patients’ lives, say congressional investigators.
A report due out Monday from the Government Accountability Office also shows that the FDA has never pulled a drug off the market due to a lack of required follow-up about its actual benefits — even when such information is more than a decade overdue.
When pressed about that policy, agency officials said they have no plans to get more aggressive.
[Flynn’s comments: I should have complained long ago.I thought I was protecting my interest. I learned if there is no complaint that there is no problem. If more people complained, then laws CAN be changed to make sure frauds won’t harm others.
I forgot the law would have protected others from those banksters! But I see in recent news how even the government can do VERY little, which explains why enforcement agencies can go NO further than what is lawful.]
Leave a Reply